Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-04

Clinical Trial Update: Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the optimal bupivacaine dose to initiate labor epidural analgesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Labor Pain, Analgesia | Phase 4 | Status: COMPLETED